Evidence map›Paper›PMID 36994311›Full record

ArticleJournal of pathology informatics2023

Pan-tumor T-lymphocyte detection using deep neural networks: Recommendations for transfer learning in immunohistochemistry.

Frauke Wilm, Christian Ihling, Gábor Méhes, Luigi Terracciano, Chloé Puget, Robert Klopfleisch, Peter Schüffler, Marc Aubreville, Andreas Maier, Thomas Mrowiec and 1 more

Erratum issuedFull text read
In one paragraph

Article in Journal of pathology informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Frauke WilmPattern Recognition Lab, Department of Computer Science, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Christian IhlingMerck Healthcare KGaA, Darmstadt, Germany.
Gábor MéhesDepartment of Pathology, University of Debrecen, Debrecen, Hungary.
Luigi TerraccianoResearch Department Pathology, Universitätsspital Basel, Basel, Switzerland.
Chloé PugetInstitute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
Robert KlopfleischInstitute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
Peter SchüfflerInstitute of General and Surgical Pathology, Technical University of Munich, Munich, Germany.
Marc AubrevilleTechnische Hochschule Ingolstadt, Ingolstadt, Germany.
Andreas MaierPattern Recognition Lab, Department of Computer Science, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Thomas MrowiecMerck Healthcare KGaA, Darmstadt, Germany.
Katharina BreiningerDepartment Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The success of immuno-oncology treatments promises long-term cancer remission for an increasing number of patients. The response to checkpoint inhibitor drugs has shown a correlation with the presence of immune cells in the tumor and tumor microenvironment. An in-depth understanding of the spatial localization of immune cells is therefore critical for understanding the tumor's immune landscape and predicting drug response. Computer-aided systems are well suited for efficiently quantifying immune cells in their spatial context. Conventional image analysis approaches are often based on color features and therefore require a high level of manual interaction. More robust image analysis methods based on deep learning are expected to decrease this reliance on human interaction and improve the reproducibility of immune cell scoring. However, these methods require sufficient training data and previous work has reported low robustness of these algorithms when they are tested on out-of-distribution data from different pathology labs or samples from different organs. In this work, we used a new image analysis pipeline to explicitly evaluate the robustness of marker-labeled lymphocyte quantification algorithms depending on the number of training samples before and after being transferred to a new tumor indication. For these experiments, we adapted the RetinaNet architecture for the task of T-lymphocyte detection and employed transfer learning to bridge the domain gap between tumor indications and reduce the annotation costs for unseen domains. On our test set, we achieved human-level performance for almost all tumor indications with an average precision of 0.74 in-domain and 0.72-0.74 cross-domain. From our results, we derive recommendations for model development regarding annotation extent, training sample selection, and label extraction for the development of robust algorithms for immune cell scoring. By extending the task of marker-labeled lymphocyte quantification to a multi-class detection task, the pre-requisite for subsequent analyses, e.g., distinguishing lymphocytes in the tumor stroma from tumor-infiltrating lymphocytes, is met.

Indexed as

Deep learningDomain adaptationImmunohistochemistryImmuno-oncologyTransfer learningTumor-infiltrating lymphocytes

Identifiers

PMID36994311
PMCPMC10040882

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read10
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.